Mode of application


Cigapan®

Biologically active food supplement. Not a cure.

COMPOSITION: Powder from reindeer horns.

It contains a natural complex of biologically active components: a large set of micro and macro elements, vitamins, a wide range of amino acids, biologically active peptides, phospholipids.

APPLICATION: CigaPan® is recommended as a biologically active food supplement - a source of calcium, phosphorus.

Indicator,

content in a daily dose of food supplements

The content in the daily dose of food supplements;

(% of recommended daily consumption)

                                       children*

                           

From 3 to 7 years

From 7 to 11 years

Over 12 years old

      Calcium

26,0 mg (2,9%)

52,0 mg (4,7%)

52,0-104,0mg (4,3-8,6%)

      Phosphorus

 12,0 mg (1,5%)

24,0 mg (2,2%)

24,0-48,0 mg (2-4%)

* - Methodical recommendations MP 2.3.1.2432 -08 "Norms of physiological energy needs and food

     substances for various groups of the population of the Russian Federation ".

Indicator

Content in daily

dose of food supplements

% of recommended

daily rate

consumption * for adults

Calcium

104,0-208,0 mg

                10-21

Phosphorus

48,0-96,0 mg

                 6-12

* -TR TR TS 022/2011 "Food products in part of its labeling"

Cigapan®
• has a tonic effect on the body;
• helps to increase vitality and efficiency;
• has a pronounced antioxidant activity;
• enhances adaptogenic resources;
• contributes to the normalization of metabolism;
• helps to improve the functional state of the endocrine, cardiovascular, urogenital systems and the gastrointestinal tract.

Numerous scientific, preclinical and clinical studies * have shown that CigaPan® contributes to:

• increase immunobiological and protective forces of the body;
• normalization of the metabolic effect (metabolism);
• regulation of redox processes, blood formation, endocrine gland function;
• restoration of hormonal balance;
• normalization of mineral metabolism, incl. osteoporosis;
• strengthen and develop the musculoskeletal tissue, and accelerate its recovery from injuries and fractures;
• rapid regeneration of damaged tissues (wounds and burns);
• has a geroprotective effect (slows down the aging process of the body);
• improves reproductive function;
• stimulates sexual function in adults;
• has a positive effect on the functional state of the liver;
• has a detoxification effect (promotes the excretion of toxins, heavy metals and radionuclides);
• reduces the side effects of radiation and chemotherapy;
• increases psycho-emotional stability;
• increases physical activity and endurance;
• accelerates recuperation after intensive work, heavy physical and mental stress;
• contributes to the rapid restoration of body functions under the influence of extreme factors, prolonged stress;
• accelerates rehabilitation processes;
• increases the period of remission in chronic diseases;
• reduces the risk of developing diseases.

Recommendations for use:

for children from 3 to 7 years, 1 tablet (200 mg each) once a day with meals;

Children from 7 years old - 2 tablets (200 mg) 1 time per day with meals;

children from 12 years old to 2 tablets (200 mg each) or 1 capsule (400 mg each) 1-2 times a day with meals;

adults take 2 capsules (400 mg) 1-2 times a day with meals.

Reception duration: 1-2 months. Repeated courses are recommended in 2-3 months.

The use of CigaPan® simultaneously with the main therapy allows to increase the effectiveness of treatment of various diseases *, protect against side effects of drugs and reduce the treatment time. Increases the period of remission in chronic diseases.

Contraindications: individual intolerance to the components. Before use, it is recommended to consult a doctor.

Cigapan® is non-toxic, antimutagenic, does not cause side effects. Evaluation of the potential ability of CigaPan® to cause toxic effects and adverse long-term effects (mutagenic, etc.) showed complete safety of its use.

Children's, adult, sports packaging differ only in packaging design, release form and dosage, the composition is the same.
For athletes, specialized, economical packaging is produced - 90 capsules of 400mg each.
AT THE PRESENT TIME, CIGAPAN® IS ONE OF THE MOST INVESTIGATED AND CLINICALLY STUDYED BIOLOGICALLY ACTIVE ADDITIVES.

ANALYSIS OF CLINICAL EFFICIENCY OF CIGAPAN® IN COMPLEX TREATMENT IN ADULTS *:

* metabolic syndrome (high risk of cardiovascular disease and type 2 diabetes); diabetes mellitus type I and II; hypertension 1-2 degrees with concomitant obesity (against the background of a calorie-reduced hyponatric, lipid-lowering, anti-atherosclerotic diet); coronary heart disease (CHD); diffuse enlargement of the thyroid gland I-II degree, hyperfunction, endocrine ophthalmopathy; hypofunction of the thyroid gland; chronic destructive-inflammatory diseases of the gastrointestinal tract (gastric ulcer and 12 duodenal ulcer, gastritis); hepatitis B and C; enterovirus infection; impaired functions of the urogenital system (impotence, chronic prostatitis, testicular hypofunction, oligozoospermia, asthenozoospermia, deterioration of erection quality, decreased libido); tuberculosis, including when combined with type 2 diabetes mellitus; Hodgkin's disease; during the period of clinical and hematological compensation in patients with thrombocytopenia (ITP); hemophilia and patients with intact blood coagulation system; osteoporosis, musculoskeletal injuries, including fractures; gunshot wounds; conditions associated with psychological and physical overloads: in extreme conditions when performing combat tasks by employees of special units, among athletes of the highest and highest qualifications; neurological diseases accompanied by degenerative-dystrophic and painful manifestations; acute poisoning with psychopharmacological drugs, narcotic drugs, carbon monoxide gas; asthenized, weakened patients, as well as drug-addicted patients as an aid, facilitating "breaking", as well as in remission; persons who, by the nature of their activities, have been exposed to ionizing radiation or are living in areas contaminated as a result of accidents; nursing mothers living in ecologically unfavorable regions.

* According to clinical tests in the Institute of Neurology, State University State Research Center of Preventive Medicine Ministry of Health, Institute of Nutrition, Institute of Physical Culture and Sports, Federal Center of Medical Sexology and Sexual pathology Institute of Psychiatry, Medical Radiological Research RAMS Center for Hematology Research Medical Sciences Center, Main Military Clinical Hospital The Ministry of Internal Affairs of Russia, the Institute of Pediatrics and Pediatric Surgery of the Ministry of Health of the Russian Federation, the Institute of Emergency Care N.V. Sklifosovsky, Central Research Institute of Tuberculosis, Clinic RNII Research Institute of Gerontology, FPPO MMA. THEM. Sechenov, Research Center EFiS, Neurological Department of St. Petersburg. Clinical Hospital of the Russian Academy of Sciences, RNC X-ray Radiology of the Ministry of Health of the Russian Federation, Research Institute of Influenza of the Russian Academy of Medical Sciences, Municipal Healthcare Institution “Volskaya Children's Hospital” of the Ministry of Health of the Russian Federation, OMON police department of Moscow.

EFFICIENCY AND SAFETY OF THE APPLICATION OF CIGAPAN® IN PEDIATRIC PRACTICE CONFIRMED BY SPECIAL RESEARCHES IN COMPLEX TREATMENT *:

* bronchial asthma; dysfunctional disorders of the gastrointestinal tract, including dysbacteriosis 2-3 degrees; vagotonic type of vascular dystonia; osteoporosis due to genetic causes: hereditary disorders of phosphorus-potassium metabolism (rachitopodobnye diseases), connective tissue diseases, osteopathies; atopic dermatitis; children with nephrotic glomerulonephritis who received long-term therapy with prednisone; pathologies caused by living in radiation-contaminated areas; with microelements in children living in ecologically unfavorable regions.

* Conducted at the Moscow Institute of Pediatrics and Pediatric Surgery of the Ministry of Health of the Russian Federation and the Municipal Healthcare Institution "Volya Children's Hospital" of the Ministry of Health of the Russian Federation.

 

Product form: 200 mg tablets, 400 mg capsules, in a package of 30, 60, 90,120 pieces.
Storage conditions: at a temperature not higher than + 25C.
Shelf life: 3 years.
Conditions of implementation: Through the pharmacy network and specialized departments of the distribution network.
Manufacturer (manufacturer): PLANET HEALTH LLC, 249360, Kaluga region, s. Khvastovichi Str. 2nd Lesnaya, 10, of.26
(production address: 249360, Kaluga region, Khvastovichi village, Lesnaya st., 6) RUSSIA, t. +7 (484) 539-12-62.
TU 9219-001-20739463-2015

SGR No. RU.77.99.88.003.E.000362.01.16 of January 28, 2016

EAU